The impact of the COVID-19 pandemic on melanoma diagnoses.
Patrick WeltlerKlemens RappersbergerPeter FilzmoserIgor VujicPublished in: JEADV clinical practice (2022)
The significant lower number of histopathologic diagnoses of melanoma during 'Lockdown 1' may be explained by postponed or missed patient consultations. This assumption is supported by the demonstration of a higher tumour thickness in July and August 2020, compared to 2019.